{"disease":{"id":"colorectal-cancer-metastatic","name":"colorectal cancer metastatic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06864338","title":"Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test","phase":"","overall_status":"RECRUITING","enrollment_count":2700,"lead_sponsor_name":"Mainz Biomed","has_results":false},{"nct_id":"NCT06342440","title":"Early Detection of Advanced Adenomas and Colorectal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT05933876","title":"The Impact of Radiotherapy on Oligometastatic Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Institut Investigacio Sanitaria Pere Virgili","has_results":false},{"nct_id":"NCT06445062","title":"Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":1130,"lead_sponsor_name":"Revolution Medicines, Inc.","has_results":false},{"nct_id":"NCT06440902","title":"Exploration of Therapeutic Strategies for NeoRAS Wild-type Metastatic Colorectal Cancer Based on Circulating Tumor DNA","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":1100,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT04513457","title":"Chemotherapy for Resectable Colorectal Liver Metastases","phase":"","overall_status":"COMPLETED","enrollment_count":967,"lead_sponsor_name":"Fundación de Investigación Biomédica - Hospital Universitario de La Princesa","has_results":false},{"nct_id":"NCT00911170","title":"PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":847,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT01571284","title":"Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":781,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT05475041","title":"Perioperative Outcomes of Simultaneous Colorectal and Liver Resections","phase":"","overall_status":"COMPLETED","enrollment_count":766,"lead_sponsor_name":"Fondazione Poliambulanza Istituto Ospedaliero","has_results":false},{"nct_id":"NCT04140526","title":"Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":733,"lead_sponsor_name":"OncoC4, Inc.","has_results":false},{"nct_id":"NCT04322539","title":"A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":691,"lead_sponsor_name":"Hutchison Medipharma Limited","has_results":true},{"nct_id":"NCT04482608","title":"The mCRC Patients With pMMR/MSS or dMMR/MSI-H Status Received Palliative Chemotherapy Efficacy and Survival","phase":"","overall_status":"COMPLETED","enrollment_count":671,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06353854","title":"Prospective National Cohort Evaluating Predictive Biomarkers of Resistance to Immunotherapy in Patients With MSI/dMMR Metastatic Colorectal Cancer (CORESIM)","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Federation Francophone de Cancerologie Digestive","has_results":false},{"nct_id":"NCT05919264","title":"FOG-001 in Locally Advanced or Metastatic Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":595,"lead_sponsor_name":"Parabilis Medicines, Inc.","has_results":false},{"nct_id":"NCT01365169","title":"Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients\"","phase":"NA","overall_status":"RECRUITING","enrollment_count":590,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06202417","title":"Fruquintinib in Refractory Metastatic Colorectal Cancer: A Real-world Study","phase":"","overall_status":"COMPLETED","enrollment_count":520,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT07224724","title":"Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT07031570","title":"Efficacy and Safety of DEB-TACE Combined With HAIC Versus HAIC Alone in Patients With Unresectable CRLM","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Peking University Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT03173001","title":"Possible Association of Intestinal Helminths and Protozoa With Colorectal Cancer Pathogenesis","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan","has_results":false},{"nct_id":"NCT05261113","title":"CE-IOUS Impact on Surgical Strategy of Liver Tumours and Liver Metastases","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"University of Regensburg","has_results":false},{"nct_id":"NCT04793958","title":"Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":461,"lead_sponsor_name":"Mirati Therapeutics Inc.","has_results":false},{"nct_id":"NCT05808790","title":"Colorectal Pulmonary Metastases: Pulmonary Metastasectomy Versus Stereotactic Ablative Radiotherapy","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":394,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false},{"nct_id":"NCT04907643","title":"Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes","phase":"NA","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT04680260","title":"OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":350,"lead_sponsor_name":"Karen-Lise Garm Spindler","has_results":false},{"nct_id":"NCT04684095","title":"The Effect of ePRO on Quality of Life and Prognosis of Patients With Unresectable Metastatic Colorectal Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":338,"lead_sponsor_name":"Harbin Medical University","has_results":false},{"nct_id":"NCT01174121","title":"Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":332,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04607668","title":"Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":326,"lead_sponsor_name":"G1 Therapeutics, Inc.","has_results":true},{"nct_id":"NCT06992648","title":"Trifluridine/Tipiracil Plus Regorafenib vs Trifluridine/Tipiracil Plus Bevacizumab for Refractory Metastatic Colorectal Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":302,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT06462963","title":"OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)","phase":"NA","overall_status":"RECRUITING","enrollment_count":302,"lead_sponsor_name":"European Organisation for Research and Treatment of Cancer - EORTC","has_results":false},{"nct_id":"NCT07001085","title":"ctDNA Monitoring in Patients With HCC and mCRC","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT00819780","title":"PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":285,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT04776655","title":"Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":280,"lead_sponsor_name":"Azienda USL Reggio Emilia - IRCCS","has_results":false},{"nct_id":"NCT07004413","title":"Continuous or Intermittent Cetuximab Plus FOLFIRI as First-line Treatment in RAS/BRAF Wild-type mCRC Patients","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":267,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT00418938","title":"SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":266,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT07318805","title":"A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":260,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT03133273","title":"Study of the Therapeutic Response and Survival of Patients with Metastatic Colorectal Cancer (stage IV) and Treated According to the Guidelines of a Chemosensitivity Test, Oncogramme® (ONCOGRAM)","phase":"NA","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"University Hospital, Limoges","has_results":false},{"nct_id":"NCT06792435","title":"XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"Evopoint Biosciences Inc.","has_results":false},{"nct_id":"NCT02751177","title":"Detection of KRAS, NRAS et BRAF Mutations in Plasma Circulating DNA From Patients With Metastatic Colorectal Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":236,"lead_sponsor_name":"Institut de Cancérologie de Lorraine","has_results":false},{"nct_id":"NCT05625932","title":"TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":232,"lead_sponsor_name":"Galician Research Group on Digestive Tumors","has_results":false},{"nct_id":"NCT05129787","title":"Ablation vs Resection of Colorectal Cancer Liver Metastases","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":230,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT02282722","title":"Improving Informed Consent for Palliative Chemotherapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":216,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":true},{"nct_id":"NCT01721954","title":"FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":209,"lead_sponsor_name":"Sirtex Medical","has_results":true},{"nct_id":"NCT05513716","title":"Molecular Characterisation of Colorectal Cancer Peritoneal Metastases","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"The Christie NHS Foundation Trust","has_results":false},{"nct_id":"NCT04776837","title":"Predicting Disease Progression and/or Recurrence in Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT06849362","title":"Multicenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal Cancer","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200,"lead_sponsor_name":"Yue Gou","has_results":false},{"nct_id":"NCT06682247","title":"A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Feng Wang","has_results":false},{"nct_id":"NCT04525807","title":"Precision Medicine for Colorectal Cancer Liver Metastasis Guided by Multi-omics Data Under the Umbrella Theory","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT03733184","title":"Development of an IDEAL Framework to Standardise Cytoreductive Surgery for Colorectal Peritoneal Metastases","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"University of Manchester","has_results":false},{"nct_id":"NCT06027775","title":"Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as Adjuvant Therapy for Initially Unresectable Colorectal Cancer Liver Metastases","phase":"","overall_status":"COMPLETED","enrollment_count":198,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05727163","title":"FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":194,"lead_sponsor_name":"Sun Yat-sen University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}